BCAX
Bicara Therapeutics

73
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 11,
Pre-Market

Estimated EPS

-$0.54

Estimated Rev

$0M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
-$0.54
--
--
N/A
Q2 '25
-$0.55
-$0.50
9.75%
BEAT
Q1 '25
-$0.41
-$0.68
-63.86%
MISSED
Q4 '24
-$0.33
-$0.39
-18.47%
MISSED
Q3 '24
-$0.41
-$1.60
-290.24%
MISSED

Latest BCAX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.